SEC Form 4 · accession 0001193125-26-393147
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James R Tobin
Director
Period of report
Sep 15, 2026
Accepted (ET)
Sep 16, 2026 · 4:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001237831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 15, 2026 | M | 15,000 | $53.75 | A | 15,000 | D | |
| Class A Common Stock | Sep 15, 2026 | M | 15,000 | $63.68 | A | 30,000 | D | |
| Class A Common StockF1 | Sep 15, 2026 | S | 30,000 | $74.5834 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $53.75 | Sep 15, 2026 | M | 15,000 | D | — | Jan 26, 2034 | Class A Common Stock | 15,000 | 0 | D |
| Stock Option (Right to Buy Class A Common Stock)F3 | $63.68 | Sep 15, 2026 | M | 15,000 | D | — | Jan 27, 2032 | Class A Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.33 to $74.96, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2These options were granted on January 26, 2024 and are fully vested.
- F3These options were granted on January 27, 2022 and are fully vested.